Home » Stocks » Tilray

Tilray, Inc. (TLRY)

Stock Price: $6.96 USD -0.05 (-0.71%)
Updated Jul 2, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 869.04M
Revenue (ttm) 179.49M
Net Income (ttm) -474.99M
Shares Out 108.20M
EPS (ttm) -4.61
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 2, 2020
Last Price $6.96
Previous Close $7.01
Change ($) -0.05
Change (%) -0.71%
Day's Open 7.15
Day's Range 6.89 - 7.28
Day's Volume 4,180,478
52-Week Range 2.43 - 49.49

More Stats

Market Cap 869.04M
Enterprise Value 1.17B
Earnings Date (est) Sep 1, 2020
Ex-Dividend Date n/a
Shares Outstanding 108.20M
Float 82.45M
EPS (basic) -4.61
EPS (diluted) -4.61
FCF / Share -3.41
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 19.51M
Short Ratio 1.32
Short % of Float 18.23%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 4.84
PB Ratio 5.62
Revenue 179.49M
Operating Income -341.29M
Net Income -474.99M
Free Cash Flow -363.03M
Net Cash -302.65M
Net Cash / Share -2.42
Gross Margin -11.95%
Operating Margin -190.14%
Profit Margin -242.30%
FCF Margin -202.25%
ROA -13.92%
ROE -166.34%
ROIC -63.20%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (16)

Buy 2
Overweight 1
Hold 12
Underweight 0
Sell 1

Analyst Consensus: Overweight

Price Target

(33.48% upside)
Current: 6.96
Target: 9.29
*Average 12-month price target from 12 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth287.15%110%62.43%-
Gross Profit-23.5014.2811.382.67
Operating Income-300-57.84-7.50-7.05
Net Income-321-67.72-7.81-7.88
Shares Outstanding10083.0175.0075.00
Earnings Per Share-3.20-0.82-0.10-0.11
Operating Cash Flow-258-46.25-6.00-3.32
Capital Expenditures-67.16-49.49-10.89-0.49
Free Cash Flow-325-95.73-16.89-3.81
Cash & Equivalents96.795182.327.53
Total Debt43042951.2228.70
Net Cash / Debt-33388.47-48.89-21.17
Book Value285198-4.852.53
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Tilray, Inc.
Country Canada
Employees 1,646
CEO Brendan Kennedy

Stock Information

Ticker Symbol TLRY
Stock Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Unique Identifier NASDAQ: TLRY
IPO Date July 19, 2018


Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products to patients, physicians, pharmacies, governments, and hospitals; and for researchers for commercial purposes, and compassionate access and clinical research applications. It operates in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, the United Kingdom, the United States, and South Africa. The company was incorporated in 2018 and is headquartered in Nanaimo, Canada.